366
Participants
Start Date
January 6, 2023
Primary Completion Date
January 20, 2025
Study Completion Date
January 20, 2025
Research Site, Aichi
Research Site, Chiba
Research Site, Fukuoka
Research Site, Fukushima
Research Site, Hiroshima
Research Site, Hokkaido
Research Site, Hyōgo
Research Site, Ibaraki
Research Site, Ishikawa
Research Site, Kagoshima
Research Site, Kanagawa
Research Site, Kyoto
Research Site, Mie
Research Site, Nara
Research Site, Numakunai
Research Site, Osaka
Research Site, Tokyo
Research Site, Tottori
Lead Sponsor
AstraZeneca
INDUSTRY